Esther Cho
Consigliere Generale presso KEROS THERAPEUTICS, INC.
Provenienza dei contatti di primo grado di Esther Cho
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Esther Cho tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Founder Chief Operating Officer Corporate Officer/Principal | |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Internet Software/Services | Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree | |
Periodontix, Inc.
 Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ACI Global Corp., Periodontix, Inc. is a biopharmaceutical company that specializes in researching and developing next-generation antimicrobial agents for the prevention and treatment of periodontal disease. The company is based in Watertown, MA. Periodontix was acquired by Demegen, Inc. on July 16, 2001 for $8.02 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of New Hampshire | College/University | Graduate Degree | |
Pontifax Management Co. Ltd.
 Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax Management Co. Ltd. (Pontifax) is a venture capital firm founded in 2004 by Eliyahu Hurvitz. The firm is headquartered in Herzliya Pituach, Israel. | Investment Managers | Chief Executive Officer Founder | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
| SCISPARC LTD. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Spearhead Investments (Bio) Ltd. | Chairman | ||
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Director/Board Member Director/Board Member | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Director/Board Member | |
NS Pharma, Inc.
 NS Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Nippon Shinyaku Co., Ltd., NS Pharma, Inc. operates as a biopharmaceutical company. The company is based in Paramus, NJ. | Pharmaceuticals: Major | President | |
| Harvard Business School | College/University | Masters Business Admin Undergraduate Degree | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Allium Ltd. | Director/Board Member | ||
Raziel Therapeutics RT Ltd.
 Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Pontifax Group | Founder | ||
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member Director/Board Member | |
CathWorks Ltd.
 CathWorks Ltd. Medical SpecialtiesHealth Technology CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel. | Medical Specialties | Director/Board Member | |
Aliment Capital Llc
 Aliment Capital Llc Investment ManagersFinance Aliment Capital LLC (Aliment Capital) is a venture capital subsidiary of Pontifax Management Co. Ltd. founded in 2014 by Philip Robert Erlanger and Ben Belldegrun. The firm is headquartered in California, United States. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology LB Pharmaceuticals, Inc. provides pharmaceutical services. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Pontifax (Cayman) III LP | Investment Managers | Director/Board Member | |
| Pontifax (Israel) III LP | Investment Managers | Director/Board Member | |
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The company is based in Hertsliya, Israel and was founded in 2015. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Pontifax Management 4 Gp 2015 Ltd. | Corporate Officer/Principal Corporate Officer/Principal | ||
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Biotechnology | Director/Board Member | |
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
89Bio Ltd.
 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Part of 89bio, Inc., 89Bio Ltd. is an Israeli company that develops therapies and drugs for the treatment of patients living with nonalcoholic steatohepatitis. The company is based in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Graviton Bioscience Corp.
 Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Graviton Bioscience Corp. develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases. The company is based in New York, NY. The company was founded by Samuel D. Waksal. Samuel D. Waksal has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. Specifically, they are developing a gene replacement approach to treat autosomal dominant Alzheimer's disease caused by mutations in the presenilin 1 gene. The company's therapy directly addresses the underlying genetic cause of the disease. | Biotechnology | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 29 |
| Israele | 21 |
| Svizzera | 3 |
Settori
| Health Technology | 37 |
| Finance | 6 |
| Consumer Services | 4 |
| Technology Services | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 166 |
| Independent Dir/Board Member | 51 |
| Corporate Officer/Principal | 44 |
| Chief Tech/Sci/R&D Officer | 15 |
| Undergraduate Degree | 14 |
Contatti più connessi
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Tomer Kariv | 46 |
| Ran Nussbaum | 38 |
| Mary Gray | 27 |
| Alon Lazarus | 18 |
| Julius Knowles | 17 |
| Nima Farzan | 12 |
| Alpna Seth | 11 |
| Jasbir Seehra | 9 |
| Simon Cooper | 8 |
| Keith Regnante | 7 |
| Christopher Rovaldi | 7 |
| Claudia Ordonez | 7 |
| Jennifer Lachey | 6 |
| Robin Wagner | 4 |
- Borsa valori
- Insiders
- Esther Cho
- Connessioni Società
